Quantcast

Latest Low-density lipoprotein Stories

2014-03-27 04:20:44

Companies to Host Investor Conference Call on Alirocumab on March 31 at 9 AM EDT PARIS and TARRYTOWN, N.Y., March 27, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from alirocumab clinical studies will be presented at the American College of Cardiology's (ACC) 63rd Annual Scientific Session in Washington, D.C. March 29-31. Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein...

2014-03-24 20:23:34

Five Phase 3 Studies With Evolocumab (AMG 145) to be Featured in Late-Breaking and Clinical Research Presentations - Data Form the Basis of Global Filing Plan THOUSAND OAKS, Calif., March 24, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present pivotal Phase 3 data from five clinical studies evaluating evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density...

2014-03-19 08:28:25

CARLSBAD, Calif., March 19, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has initiated a Phase 1 clinical study for ISIS-ANGPTL3(Rx), an antisense drug targeting angiopoietin-like 3 protein (ANGPTL3), an independent risk factor for cardiovascular disease. ISIS-ANGPTL3(Rx) is designed to act as a broad dyslipidemia agent. By reducing ANGPTL3, ISIS-ANGPTL3(Rx) has the potential to reduce LDL-cholesterol and triglycerides, and to increase...

2014-03-17 08:30:17

Study Meets Primary Endpoint of LDL Cholesterol Reduction THOUSAND OAKS, Calif., March 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C). The percent reduction in LDL-C, or "bad" cholesterol, was clinically meaningful and statistically...

2014-03-14 20:21:47

WOODBRIDGE, ON, March 14, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that it has granted previously reserved stock options to certain of its directors, officers, employees and consultants in recognition of their contributions made in 2012. Options to acquire a total of 4,075,000 common shares of the Company were granted in...

2014-03-13 23:02:07

Center for Primary Care participates in and sponsors the CSRA Heart Walk, raising awareness for cardiovascular disease and heart health. Evans, GA (PRWEB) March 13, 2014 Center for Primary Care recently participated in and sponsored the CSRA Heart Walk. The walk took place at 8:30 a.m. March 8 and raised awareness for cardiovascular disease and heart health. Center for Primary Care was on hand at the walk to offer tips and information for maintaining a healthy heart. Cardiovascular...

2014-03-03 23:01:45

Kyowa Hakko USA announces that Pantesin is a comprehensive and safe dietary supplement that supports healthy cholesterol levels. New York, NY (PRWEB) March 03, 2014 A recently published study in Vascular Health and Risk Management showed that Pantesin® Pantethine was effective in lowering cardiovascular risk markers in study participants with low to moderate risk factors who were eligible for statin therapy. Specifically when compared to placebo, Pantesin showed significant changes...

Adding More Fish To Your Diet Can Increase Good Cholesterol
2014-03-03 12:49:29

Lee Rannals for redOrbit.com - Your Universe Online Adding more fish to your diet could help boost good cholesterol levels, according to a new study published in PLOS ONE. Scientists at the University of Eastern Finland found that people who increase their intake of fish to a minimum of three to four fatty fish servings per week could increase the number of HDL particles in their blood, which are believed to protect against cardiovascular diseases. Although many studies have been...

2014-02-28 23:26:13

Icahn School of Medicine at Mount Sinai study suggests early-stage atherosclerosis is reversible, and identifies new genetic targets for fighting advanced atherosclerosis New York, NY (PRWEB) February 28, 2014 Research at Icahn School of Medicine at Mount Sinai has led to important new discoveries about the process behind regression of atherosclerosis, the main underlying cause of heart attack and stroke. In the paper published today in PLoS Genetics, scientists from Mount Sinai and the...

Cholesterol-Lowering Benefits Of The Strawberry
2014-02-26 07:15:44

[ Watch the Video: The Health Benefits Of Strawberries ] FECYT - Spanish Foundation for Science and Technology A team of volunteers ate half a kilo of strawberries a day for a month to see whether it altered their blood parameters in any way. At the end of this unusual treatment, their levels of bad cholesterol and triglycerides reduced significantly, according to the analyses conducted by Italian and Spanish scientists. Several studies had already demonstrated the antioxidant...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.